Saturday 17 October 2026
Export ETAOF’s income statement to Excel — free account
ETAO International Co., Ltd.
ETAOF Healthcare Health Information Services
ETAO International Co., Ltd.’s revenue for fiscal 2022 (year ended December 2022) was $58.1 million. Operating cash flow growth for five consecutive years.
0.00
0.00
NaN
Follow ETAOF
| Dec '17 | Jan '21 | Dec '21 | Dec '22 | |
|---|---|---|---|---|
P/E ratio |
— | — | 0.00 | 0.00 |
Altman Z-Score |
— | — | 8.82 | (58.66) |
P/S ratio |
— | — | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | — | 1.71 | (150.41) |
P/FCF ratio |
— | — | 0.00 | 93.59 |
Beneish M-Score |
— | — | — | (89.57) |
P/Operating CF |
— | — | (46,415.85) | 89.46 |
P/B ratio |
— | — | 26.68 | 0.00 |
Price to Tangible BV |
— | — | 26.68 | 0.00 |
EV/Sales |
— | — | 0.00 | 0.00 |
EV/EBITDA |
— | — | 0.00 | 0.00 |
EV/Operating CF |
— | — | 0.00 | 92.38 |
EV/FCF |
— | — | 0.00 | 92.38 |
Quick Ratio |
— | 0.17 | 0.51 | 0.65 |
Current Ratio |
— | 0.18 | 0.69 | 0.77 |
Net Debt/EBITDA |
— | 1.02 | 2.85 | 0.02 |
Debt/Assets |
0.00% | 0.00% | 0.17% | 2.01% |
Debt/Equity |
— | 0.00 | 0.00 | (0.18) |
Asset Turnover |
— | 0.00 | 0.39 | 0.42 |
Operating CF/Net income |
— | 0.76 | 0.02 | (0.01) |
Capex/Depreciation |
— | — | (1.39) | (0.32) |
Interest Coverage |
— | (304.09) | (10.23) | (1,463.46) |
| — | (0.63%) | (10.20%) | (1,209.41%) | |
| — | (1.22%) | (7.62%) | (651.90%) | |
ROIC |
— | 0.00% | (2.36%) | 0.00% |
Return on Tangible Assets |
— | 20.30% | (143.62%) | (9,261.09%) |
Average Days of Receivables |
— | — | 59.65 | 50.90 |
Research and Development Expense of Revenue |
— | — | 1.72% | 3.67% |
Selling, General and Administrative Expense of Revenue |
— | — | 38.94% | 1,298.69% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.73 | 0.02 |
Share Based Compensation of Revenue |
— | — | 9.37% | 1,267.65% |
Graham Net Nets |
— | — | 0.00 | (0.03) |
Graham Number |
— | — | 0.00 | 69.48 |
Earnings Yield |
— | — | (1.40%) | (88.55%) |
Free Cash Flow Yield |
— | — | 0.00% | 1.07% |
Revenue per Share |
— | 0.00 | 10.67 | 11.61 |
Operating CF per Share |
— | (0.04) | (0.05) | 2.16 |
Capex per Share |
— | 0.00 | (0.47) | (0.13) |
Free Cash Flow per Share |
— | (0.04) | (0.52) | 2.04 |
Cash per Share |
— | 0.05 | 2.20 | 2.83 |
Shareholders Equity per Share |
— | 7.45 | 30.85 | (1.20) |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 7.45 | 30.85 | (1.20) |
Free Cash Flow |
— | (0.25) | (2.61) | 10.19 |
Working Capital |
— | (1.64) | (11.99) | (8.01) |
Capital Expenditures |
— | — | (2.36) | (0.63) |
Net Current Asset Value |
— | (1.64) | (41.31) | (32.53) |
EV/EBIT |
— | — | 0.00 | 0.00 |
Capex to Sales |
— | — | 0.04 | 0.01 |
Price to Operating Income |
— | — | 0.00 | 0.00 |
| Other line items | ||||
Depreciation/Fixed assets |
— | — | 0.09 | 0.11 |
Cash ROIC |
— | (0.48%) | (1.57%) | 110.21% |
Accounts Receivable Turnover |
— | — | 0.00 | 6.91 |
Accounts Payable Turnover |
— | — | 0.00 | 5.23 |
Inventory Turnover |
— | — | 0.00 | 19.20 |
Average Days of Payables |
— | — | 72.53 | 70.68 |
Days of Inventory on Hand |
— | — | 20.48 | 18.59 |
Average Receivables |
— | — | — | 8.41 |
Average Payables |
— | — | — | 7.47 |
Average Inventory |
— | — | — | 2.03 |
Average Assets |
— | 27.27 | 138.33 | 137.55 |
Average Common Equity |
— | 52.54 | 103.40 | 74.14 |
Columns are period end dates · fundamentals updated 5 Oct 2026